STOCK TITAN

Addentax Group Corp. Form 4 Filings

ATXG NASDAQ

Every Form 4 that Addentax Group Corp. (ATXG) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow ATXG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ATXG filings page.

Rhea-AI Summary

ADDENTAX GROUP CORP. (ATXG) director and ten percent owner Hong Zhiwang reported purchasing 218,750 shares of common stock on August 18, 2026 at a price of $4.80 per share in a non-derivative transaction. Following this open-market or private purchase, his directly held position is 225,174 common shares.

Rhea-AI Summary

Hong Zhida reported acquisition or exercise transactions in this Form 4 filing.

ADDENTAX GROUP CORP. reports that CEO Hong Zhida received a grant of 12,222 shares of common stock at $0.0000 per share under the Addentax Group Corp. 2024 Equity Incentive Plan. The Compensation Committee approved the grant on March 24, 2026, and the award agreement was executed on April 8, 2026.

This Form 4/A amendment corrects his beneficial holdings after the grant to 30,155 shares, instead of 23,815 shares previously reported. All other information from the original insider report remains unchanged.

Rhea-AI Summary

Hong Zhida reported acquisition or exercise transactions in this Form 4 filing.

ADDENTAX GROUP CORP. reported that Chief Executive Officer Hong Zhida received a grant of 12,222 shares of common stock at $0.00 per share under the Addentax Group Corp. 2024 Equity Incentive Plan. The grant was approved by the Compensation Committee on March 24, 2026, and the award agreement was executed on April 8, 2026. Following this award, he holds 23,815 shares of common stock directly.

Rhea-AI Summary

ADDENTAX GROUP CORP. Chief Operating Officer Wu Rui reported an “other” transaction involving 33,500 shares of common stock at $5.00 per share on May 15, 2026. After this restructuring-type event, Wu Rui holds 100,167 common shares directly. A footnote states the shares are issuable under a Share Exchange Agreement dated May 15, 2026, subject to customary closing conditions.

Rhea-AI Summary

Wu Rui reported acquisition or exercise transactions in this Form 4 filing.

Addentax Group Corp. granted Chief Operating Officer Wu Rui 66,667 shares of common stock. The shares were awarded at a price of $0.00 per share under the Addentax Group Corp. 2024 Equity Incentive Plan, bringing Wu Rui’s direct holdings to 66,667 shares.

The grant was approved by the Compensation Committee on March 24, 2026, and the award agreement was executed on April 8, 2026, the same date reported for the transaction.

Rhea-AI Summary

Addentax Group Corp. director Form 4 filing reports an insider stock sale. A company director sold 23,095 shares of Addentax Group Corp. common stock on 09/08/2025 at a price of $0.52 per share. After this transaction, the reporting person directly owns 0 shares of the company’s common stock. The filing is made by a single reporting person and covers only non-derivative securities; no derivative positions are reported.